ASX small caps leading the fight against cancer
StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses ASX health and biotechnology companies focused on fighting cancer.
Populating the expert panel this week is Tim Boreham, health & biotech journalist, Leslie Chong, CEO & managing director of Imugene (ASX:IMU) and Steven Yatomi-Clarke, CEO & managing director of Prescient Therapeutics (ASX:PTX).
The group discusses a range of topics, including appraising biotech stocks and valuing milestones, key development stages for oncology treatments, the importance of banking and M&A skills on biotech boards, key trends and investment hotspots and much more.
Related Topics
Related Stories
SUBSCRIBE
Get the latest breaking news and stocks straight to your inbox.
It's free. Unsubscribe whenever you want.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
